Oryzon Genomics S.A. (0RDB.L) Stock Price
€2.72 0%
to add to portfolio
AI Score
-
Alternative
4 -
Fundamental
6 -
Technical
4
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Oryzon Genomics S.A., AI stock picks, stock alerts and much more.
0RDB.L AI Stock Analysis
AI stock analysis for 0RDB.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Oryzon Genomics S.A. (0RDB.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Oryzon Genomics S.A. (0RDB.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Oryzon Genomics S.A. (0RDB.L), currently trading at €2.72, will... Sign up to access price prediction.
About 0RDB.L
-
Oryzon Genomics S.
-
Symbol
0RDB.L
-
Market
LSE
-
Industry
Medical - Pharmaceuticals
-
Market Cap
210.8M
Similar Stocks
 |
Vertex Pharmaceuticals Incorporated 0QZU.L |
$394.5 0.3% |
7 |
 |
Neurocrine Biosciences 0K6R.L |
$142.1 0.9% |
7 |
 |
Emergent BioSolutions Inc. 0IGA.L |
$8.23 1.5% |
5 |
 |
Abeona Therapeutics Inc. 0H7R.L |
$6.64 2.1% |
5 |
 |
Esperion Therapeutics 0IIM.L |
$2.8 2.9% |
6 |
News
0RDB.L Alternative Data
Web Traffic
Oryzon Genomics S.A. receives an estimated 7744 monthly visitors to oryzon.com, which is down by -24.3% over the last month.
-
Web Traffic
7744
-
Change from Previous Month
24.3%
-
3 Month Change
19.7%
-
YoY Change
19.7%
Job Postings
Oryzon Genomics S.A. currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Reddit Mentions
Oryzon Genomics S.A. has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Followers
10,128 are following Oryzon Genomics S.A. on LinkedIn, up by 1.1% over the last month.
-
LinkedIn Followers
10128
-
Daily Change
1.1%
-
1 Month Change
1.1%
-
3 Month Change
3.6%
-
YoY Change
3.6%
Business Outlook
According to employee reviews, the business outlook among employees at Oryzon Genomics S.A. is 29 out of 100 (bearish).
-
Business Outlook
29
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Employees
According to LinkedIn, Oryzon Genomics S.A. has 58 employees, down by -1.7% over the last month.
-
LinkedIn Employees
58
-
Daily Change
1.7%
-
1 Month Change
1.7%
-
3 Month Change
0%
-
YoY Change
0%
News Mentions
Oryzon Genomics S.A. was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
0RDB.L Financials
0RDB.L Key Metrics
-
Total Revenue
$0
-
Net Income
$113K
-
Earnings per Share
$0.0018
-
Free cash flow
$0
-
EBITDA
$3.7M
-
EBITDA Ratio
0
-
Total Assets
$118.6M
0RDB.L 2-year Revenue & Income
0RDB.L 2-year Free Cash Flow
0RDB.L Technicals
0RDB.L SMA
0RDB.L RSI
FAQ
What's the current price of Oryzon Genomics S.A. (0RDB.L) Stock?
The price of an Oryzon Genomics S.A. (0RDB.L) share is €2.72.
What's the market cap of Oryzon Genomics S.A.?
The current market cap of Oryzon Genomics S.A. is 210.8M.
What are some stocks similar to Oryzon Genomics S.A. (0RDB.L) that investors often compare it to?
Oryzon Genomics S.A. (0RDB.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc., Abeona Therapeutics Inc. and Esperion Therapeutics.
What is the forecast for Oryzon Genomics S.A.'s stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Oryzon Genomics S.A.'s stock price to be around €2.68 in 2026. Starting from the current price of €2.72, this represents a 1.6% change in price, indicating a neutral outlook for the stock.
How to buy Oryzon Genomics S.A. (0RDB.L) Stock?
Oryzon Genomics S.A. stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Oryzon Genomics S.A. shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.